Drugs that contain Dexrazoxane Hydrochloride
1. Totect patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6727253 | CLINIGEN | Treatment of accidental extravasation of anthracyclines |
Mar, 2020
(4 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE) | Sep 06, 2014 |
Market Authorisation Date: 06 September, 2007
Treatment: Treatment of extravasation resulting from iv anthracycline chemotherapy
Dosage: INJECTABLE;INJECTION
More Information on Dosage
TOTECT family patents
